Related Experiment Video
Updated: Jul 10, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
Nanoparticles and microparticles as vaccine-delivery systems
Manmohan Singh1, Aravind Chakrapani, Derek O'Hagan
1Novartis Vaccines, 4560 Horton Street, Emeryville, CA 94608, USA. manmohan.singh@novartis.com
Particulate vaccine delivery systems, like micro- and nanoparticles, enhance immune responses by co-delivering antigens and adjuvants to immune cells. Surface modifications can improve cellular uptake, paving the way for human trials.
Area of Science:
- Immunology
- Biotechnology
- Materials Science
Background:
- Particulate vaccine delivery systems (e.g., emulsions, microparticles, liposomes) mimic pathogen sizes.
- Sophisticated systems incorporate immunostimulatory adjuvants with antigens for targeted delivery.
Purpose of the Study:
- To explore the synergistic effects of combining antigens and adjuvants within micro- and nanoparticle delivery systems.
- To investigate how surface property manipulation of these particles enhances cellular uptake.
Main Methods:
- Utilizing micro- and nanoparticulate delivery systems for co-delivery of antigens and adjuvants.
- Modifying particle surface properties to optimize interaction with antigen-presenting cells.
Main Results:
- Synergistic immune responses were observed, exceeding those from standalone adjuvants or delivery systems.
- Micro- and nanoparticles demonstrated enhanced uptake by target immune cells through surface property manipulation.
Conclusions:
- Micro- and nanoparticle-based vaccine delivery systems show significant potential for enhancing immune responses.
- Further evaluation in human trials is the crucial next step for these advanced vaccine technologies.
More Related Videos
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted